From TekinHealthHealthcare Tech Field Notes

The Cigna Group announced a partnership with OpenAI to build AI into clinical workflows at Cigna Healthcare and its Accredo Specialty Pharmacy, starting with cancer care. The first tool gives oncology nurses and case managers an AI-enabled interface that pulls together a patient's clinical, pharmacy, behavioral and benefits data into one view, along with patient-reported information like side effects and preferences. Cigna says the goal is to help clinical teams spot needs and coordinate support between physician visits, under human and clinician oversight. The companies plan to expand the collaboration to other conditions over time.

Why it's notable: It puts a large national payer's AI push directly into oncology case management workflows that clinics and specialty pharmacies already touch, rather than just member-facing chat.

CMS announced that its ACCESS model will add tracks for heart failure, chronic obstructive pulmonary disease, substance use disorder and tobacco cessation starting in spring 2027. ACCESS is a voluntary 10-year Medicare model that pays participants for technology-enabled chronic care between visits. It launched on July 5, 2026, with tracks for hypertension, diabetes, chronic musculoskeletal pain and depression. Full payment depends on patients reaching defined outcomes, such as better blood pressure control. CMS says about 160 organizations joined at launch and that three in four Medicare beneficiaries qualify for at least one track.

Why it's notable: ACCESS is Medicare's main outcome-based payment route for virtual care, remote monitoring and connected-device programs. Adding common high-cost conditions like heart failure and COPD widens the pool of patients whose between-visit care clinics and digital health partners can be paid for.

Sword Health, a virtual physical therapy company, plans to acquire Headspace's parent company OrangeDot for cash. The deal became public on August 25, 2026, through a filing with the Massachusetts Health Policy Commission. The filing did not give a price. Axios reported the deal at up to about $300 million, far below the roughly $3 billion Headspace was valued at after its 2021 merger with Ginger. Headspace offers therapy, coaching and meditation content and says its app has reached more than 100 million people. Sword formally announced the deal on September 16 and said it expects it to close by early in the fourth quarter.

Why it's notable: A former digital mental health leader is being sold at a fraction of its peak value to an AI-driven virtual care company. The deal shows the category consolidating, and it brings mental health support into the same platform employers already buy for musculoskeletal care.

CMS's proposed CY 2027 Medicare Physician Fee Schedule, released July 14, 2026, would pay for remote physiologic monitoring (RPM) and remote therapeutic monitoring (RTM) only when the clinical staff doing the work are employed by the billing practice, not by a contracted vendor. It would also limit the services to established patients, require a separately billed initiating visit before monitoring starts, and revalue the device codes. CMS is also considering bundling the codes into four new G-codes. The same rule carries forward telehealth flexibilities through 2027 and proposes a roughly 1.7% cut to the main conversion factor. Comments were due September 14; if finalized, most provisions take effect January 1, 2027.

Why it's notable: Many practices run RPM through third-party vendors, so the proposal could force them to bring monitoring in-house or drop it. It follows an OIG finding that about 43% of 2022 Medicare RPM patients did not get all three required components.

NHS England announced on July 6, 2026 that it will add an AI triage tool to the NHS App. The tool asks patients adaptive questions and directs them to a GP appointment, a pharmacy, A&E, community services or self-care. It is due to reach more than 200,000 patients in its first 12 months and all NHS App users by April 2028, and patients can still contact their practice the usual ways. NHS England says a pilot at a Sussex GP practice cut phone queues by 29%. The announcement is part of a £10 billion, three-year technology program that also expands AI notetaking for staff.

Why it's notable: It is one of the largest national deployments of AI front-door triage in primary care, and a test of whether automated routing can ease the morning phone rush at GP practices at scale.

On June 25, 2026, UpDoc publicly announced the FDA 510(k) clearance (K253281, granted in December 2025) of UpDoc V1.0. It is prescription software that talks with adults with type 2 diabetes by voice or text and adjusts their insulin within limits set by their physician. The company calls it the first FDA-cleared device to use patient-facing large language models. It says the system is deployed at Cleveland Clinic, Allegheny Health Network and UCSF Health, can order follow-up labs and writes its actions into the EHR. It was cleared as a 510(k) with an insulin dosing program as the predicate device, and it is backed by a small Stanford randomized trial published in JAMA Network Open. STAT reported that the CEO would not say whether the language model itself makes the dosing decisions.

Why it's notable: This is the first regulatory path for an AI that talks directly with patients to adjust a drug between visits, and other developers are likely to follow it. It also leaves open how much of the clinical decision the language model makes and how much fixed dosing rules make.

Cadence, which runs remote monitoring programs for hypertension, diabetes and heart failure with health systems, raised a $100 million Series C led by Spark Capital at a $1.23 billion valuation, announced June 23, 2026. The company says it works with more than 20 health systems and cares for over 100,000 active patients using home devices such as blood pressure cuffs and its own clinicians. Health systems including Corewell Health, Memorial Hermann and Duke Health invested in the round. CEO Chris Altchek told STAT the company plans to use AI agents to automate clinician work and is talking with the FDA about using agents in its hypertension program.

Why it's notable: It is one of the largest bets on outsourced remote monitoring for health systems. It comes as regulators and insurers such as UnitedHealthcare question whether monthly Medicare remote monitoring payments deliver real care.

Teladoc Health and Walmart announced on May 28, 2026 that Teladoc's virtual care would be offered nationwide through Walmart's Better Care Services platform. The service covers 24/7 urgent care for conditions like sinus and urinary tract infections, dermatology visits and nutrition counseling. Visits can be billed to insurance or paid in cash at $89, and prescriptions can be sent to Walmart pharmacies. Teladoc had already added its BetterHelp mental health service to the platform in January and said it is moving most members from subscriptions to per-visit arrangements.

Why it's notable: Low-acuity visits that used to go to primary care and urgent care clinics are increasingly sold in retail storefronts at a fixed cash price. Clinics lose those visits and see more care happen outside the patient's regular chart.

Oura introduced its Ring 5 on May 28, 2026, with plans to add a feature that tracks overnight blood pressure patterns and tells users when to see a doctor. The feature shows trends rather than systolic and diastolic readings, and it is sold as a wellness tool without FDA review under the agency's January 2026 wellness guidance. Oura said a separate feature to flag possible hypertension is being studied and will go through the FDA. The launch also added health record import and access to clinicians through Counsel Health and ResMed.

Why it's notable: Clinicians should expect patients to bring in blood pressure trends from rings and watches that no regulator has checked for accuracy. Experts quoted by STAT warned that these unvetted blood pressure features are spreading quickly.

On April 16, 2026, Hippocratic AI launched Nurse Co-Pilot, an AI voice assistant for inpatient nurses built with Cincinnati Children's Hospital Medical Center, OhioHealth and Cleveland Clinic, which are the first to use it. It starts with patient-facing tasks such as admission education, patient education, caregiver engagement and medication-related support, and the company says it can give nurses back 1 to 4 hours per shift. Hippocratic also launched an 'AI Front Door' voice agent that handles incoming patient calls.

Why it's notable: Patient-facing AI agents are moving beyond call centers onto hospital floors, taking over routine education and discharge conversations that nurses now spend hours on.

On March 10, 2026, Amazon began offering Health AI, an agent-based health assistant built on Amazon Bedrock, on Amazon.com and in the Amazon app. It had launched for One Medical members in January. With the user's permission, it pulls medical history, medications, lab results and clinical notes through health information exchanges. It then answers questions, helps with prescriptions and scheduling, and hands users to One Medical clinicians. Amazon says eligible Prime members get up to five free message-based visits for more than 30 common conditions. After that, visits cost $29 each. Amazon also says auditor and escalation agents send uncertain cases to human clinicians.

Why it's notable: A large consumer platform now puts an AI agent that reads a patient's own records in front of well over 100 million Prime members, and connects it directly to cheap virtual visits. Primary care practices will increasingly see patients who have already talked to such an agent.

Hospital operator Universal Health Services (UHS) agreed on March 9, 2026 to acquire virtual behavioral health company Talkspace for $5.25 a share, an enterprise value of about $835 million. Talkspace brings about 6,000 licensed clinicians. It says it reaches more than 200 million Americans through employer and health plan contracts. UHS says the deal gives it inpatient, outpatient and virtual mental health care in one company. It expects Talkspace to add about $280 million in revenue. The deal closed on August 18, 2026.

Why it's notable: One of the largest US behavioral hospital operators is buying a national telehealth therapy network. Virtual therapy becomes a referral path into and out of its facilities, as mental health staffing shortages limit in-person capacity.

On January 6, 2026, Utah's Office of Artificial Intelligence Policy and the startup Doctronic announced a 12-month pilot, set up through the state's regulatory sandbox, in which Doctronic's AI renews routine prescriptions for chronic conditions such as diabetes and hypertension. Reports put the list at about 192 drugs. Controlled substances, ADHD medications and injectables are excluded, and the first prescription must still come from a human clinician. The state agreed not to enforce its unprofessional-conduct rules against Doctronic as long as the company follows a contract with safety and privacy terms. Physicians review the AI's decisions at first, and uncertain cases are sent to clinicians. Doctronic told regulators its system matched physician treatment plans in 99.2% of 500 urgent care cases it reviewed.

Why it's notable: It is the first state-approved program in the US to let an AI system renew prescriptions on its own, which makes it a test case for how states may license autonomous clinical AI.

When Congress failed to pass FY2026 funding and the federal government shut down on October 1, 2025, Medicare's pandemic-era telehealth flexibilities expired with it. Medicare telehealth coverage for most services was again limited to rural patients seen at approved originating sites instead of at home, audio-only coverage ended, and CMS's Acute Hospital Care at Home waiver, used by more than 400 facilities in 39 states, also lapsed. Behavioral health telehealth was largely protected by permanent law, and CMS said providers could hold telehealth claims while Congress acted. The spending bill that ended the shutdown in November restored the flexibilities through January 30, 2026, with retroactive payment for services delivered during the lapse.

Why it's notable: For six weeks, practices and hospital-at-home programs could not be sure Medicare would pay for virtual visits, which exposed how much U.S. telehealth still depends on short-term extensions.